Dendritic cells are poised to revolutionize oncology. This type of immune therapy shows effectiveness even in late-stage ...
The phase 2 CELLVX-230 trial is assessing the potential of FK-PC101 to prevent prostate cancer recurrence and delay ...
The heart tissue showed upregulation of molecular pathways that help recruit and retain immune cells involved in inflammation ...
A novel test developed by Duke-NUS researchers enables real-time monitoring of T cells that have been engineered to fight ...
News Medical on MSN13d
Study reveals how cancer immunotherapy may cause myocarditis in some patientsOne of the more feared complications of immunotherapy, checkpoint myocarditis ... a unique protein complex that binds and responds to foreign particles known as antigens. T-cell receptors abundant in ...
Researchers develop a plug-and-play test that enables real-time monitoring of engineered T-cells, improving the precision and ...
Trials with mice in whom the researchers implanted human glioblastoma cells have already shown that the treatment is very ...
Some patients being treated with immune checkpoint inhibitors, a type of cancer immunotherapy, develop a dangerous form of heart inflammation called myocarditis. Researchers have now uncovered the ...
BriaCell’s clinical candidates for next generation breast cancer (Bria-BRES+™) and prostate cancer (Bria-PROS+™) generate robust anti-cancer ...
AC Immune Reports Positive Interim Results from Phase 2 Trial of ACI-7104.056 Active Immunotherapy in Early Parkinson’s DiseaseActive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback